Related references
Note: Only part of the references are listed.Engagement with tNOX (ENOX2) to Inhibit SIRT1 and Activate p53-Dependent and -Independent Apoptotic Pathways by Novel 4,11-Diaminoanthra[2,3-b]furan-5,10-diones in Hepatocellular Carcinoma Cells
Chia-Yang Lin et al.
CANCERS (2019)
Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell
Yudong Hu et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Antihypertensive drug-candesartan attenuates TRAIL resistance in human lung cancer via AMPK-mediated inhibition of autophagy flux
Mohammad Rasheduzzaman et al.
EXPERIMENTAL CELL RESEARCH (2018)
Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAIL in lung cancer via inhibition of autophagy flux
Mohammad Rasheduzzaman et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-κB signaling
Mohammad Rasheduzzaman et al.
LIFE SCIENCES (2018)
Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism
Tabea Wiedmer et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Enhancement of TRAIL-induced apoptosis by 5-fluorouracil requires activating Bax and p53 pathways in TRAIL-resistant lung cancers
Uddin Md. Nazim et al.
ONCOTARGET (2017)
Lanatoside C, a cardiac glycoside, acts through protein kinase Cδ to cause apoptosis of human hepatocellular carcinoma cells
Min-Wu Chao et al.
SCIENTIFIC REPORTS (2017)
Targeting autophagy in cancer
Jean M. Mulcahy Levy et al.
NATURE REVIEWS CANCER (2017)
Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy
Silvia von Karstedt et al.
NATURE REVIEWS CANCER (2017)
Resveratrol protects cardiomyocytes from doxorubicin-induced apoptosis through the AMPK/P53 pathway
Mi-Hua Liu et al.
MOLECULAR MEDICINE REPORTS (2016)
Onto better TRAILs for cancer treatment
D. de Miguel et al.
CELL DEATH AND DIFFERENTIATION (2016)
Advanced Hepatocellular Cancer: the Current State of Future Research
Louise C. Connell et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Role of reactive oxygen species-mediated MAPK and NF-κB activation in polygonatum cyrtonema lectin-induced apoptosis and autophagy in human lung adenocarcinoma A549 cells
Tao Liu et al.
JOURNAL OF BIOCHEMISTRY (2016)
Marine steroid derived from Acropora formosa enhances mitochondrial-mediated apoptosis in non-small cell lung cancer cells
Ramalingam Vaikundamoorthy et al.
TUMOR BIOLOGY (2016)
The Relationship between the Bcl-2/Bax Proteins and the Mitochondria-Mediated Apoptosis Pathway in the Differentiation of Adipose-Derived Stromal Cells into Neurons
Quanquan Wang et al.
PLOS ONE (2016)
Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment
Kasturi Muthoosamy et al.
SCIENTIFIC REPORTS (2016)
mRNA and protein dataset of autophagy markers (LC3 and p62) in several cell lines
Ruben Gomez-Sanchez et al.
DATA IN BRIEF (2016)
Therapeutic applications of TRAIL receptor agonists in cancer and beyond
Gustavo P. Amarante-Mendes et al.
PHARMACOLOGY & THERAPEUTICS (2015)
A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells
Mingning Qiu et al.
SCIENTIFIC REPORTS (2015)
Trailing TRAIL resistance: novel a gets for TRAIL sensitization in cancer cells
Rachana Trivedi et al.
FRONTIERS IN ONCOLOGY (2015)
The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells
Min Zhang et al.
PLOS ONE (2015)
Cardiac glycoside ouabain induces autophagic cell death in non-small cell lung cancer cells via a JNK-dependent decrease of Bcl-2
Annalisa Trenti et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Getting TRAIL back on track for cancer therapy
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
Depolarization controls TRAIL-sensitization and tumor-selective killing of cancer cells: crosstalk with ROS
Yoshihiro Suzuki-Karasaki et al.
FRONTIERS IN ONCOLOGY (2014)
Autophagy and Cancer Therapy
Andrew Thorburn et al.
MOLECULAR PHARMACOLOGY (2014)
Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials
M. Slingerland et al.
INVESTIGATIONAL NEW DRUGS (2013)
Differential susceptibility of gastric cancer cells to TRAIL-induced apoptosis
Nak-Mi Song et al.
ONCOLOGY REPORTS (2013)
TRAIL on trial: preclinical advances in cancer therapy
Daniel W. Stuckey et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Trial watch Cardiac glycosides and cancer therapy
Laurie Menger et al.
ONCOIMMUNOLOGY (2013)
Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors
Bokyung Sung et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Inhibition of AMPK-dependent autophagy enhances in vitro antiglioma effect of simvastatin
Maja Misirkic et al.
PHARMACOLOGICAL RESEARCH (2012)
The Role of Autophagy in Cancer: Therapeutic Implications
Zhineng J. Yang et al.
MOLECULAR CANCER THERAPEUTICS (2011)
A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment
Elizabeth A. Platz et al.
CANCER DISCOVERY (2011)
Methods in Mammalian Autophagy Research
Noboru Mizushima et al.
CELL (2010)
Cytoprotective roles for autophagy
Kevin Moreau et al.
CURRENT OPINION IN CELL BIOLOGY (2010)
New insights into apoptosis signaling by Apo2L/TRAIL
F. Gonzalvez et al.
ONCOGENE (2010)
Dysregulation of apoptosis in hepatocellular carcinoma cells
Isabel Fabregat
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Cardiac glycosides as novel cancer therapeutic agents
Robert A. Newman et al.
MOLECULAR INTERVENTIONS (2008)
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Huafeng Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
p38 MAPK plays an essential role in apoptosis induced by photoactivation of a novel ethylene glycol porphyrin derivative
J. Kralova et al.
ONCOGENE (2008)
Autophagy: from phenomenology to molecular understanding in less than a decade
Daniel J. Klionsky
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Downregulation of Bid is associated with PKC epsilon-mediated TRAIL resistance
U. Sivaprasad et al.
CELL DEATH AND DIFFERENTIATION (2007)
The apoptosis/autophagy paradox:: autophagic vacuolization before apoptotic death
RA González-Polo et al.
JOURNAL OF CELL SCIENCE (2005)
Inhibition of macroautophagy triggers apoptosis
P Boya et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The interplay between the Bcl-2 family and death receptor-mediated apoptosis
MR Sprick et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)
Recruitment of NF-κB into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis
M Zamora et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes
S Shimizu et al.
NATURE CELL BIOLOGY (2004)
The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions
C Borner
MOLECULAR IMMUNOLOGY (2003)
Share Paper
